2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

Well...that's the premise of Zomato co-founder and ex-Shark Deepinder Goyal's brand-new venture, Continue Research. He ...

Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12.4% year on year to ...

Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its ...

Pfizer and Novo Nordisk seem to want Metsera bad. Analysts are wondering, though: is the obesity biotech really worth this much effort?

A global conference showcasing AI-led scientific research revealed both the growing role of AI in academia and its persistent ...

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

Ironically enough, his initial downfall had nothing to do with Daraprim. Soon after he became infamous, federal prosecutors ...

E. John Wherry, director of Penn's Colton Center for Autoimmunity, spoke with the Inquirer about the future of immunology ...

In the world of biomedical innovation, few stories embody the spirit of perseverance, intuition, and collaboration quite like ...

Discover the surprising power of peas! These humble legumes are nutritional powerhouses, packed with protein, fibre, vitamins ...